Zhao et al. present machine-learning models to predict intraoperative hemodynamic instability in hypertensive pheochromocytoma and paraganglioma surgery. The clinical motivation is sound and the reported discrimination and decision-curve metrics indi...
This study aims to enhance individual hypertension risk prediction in Indonesia using machine learning (ML) models. The research investigates the predictive accuracy of models with and without incorporating personal hypertension history, seeking to u...
BACKGROUND: Young adults aged 25-49, at the peak of work and family responsibilities, face serious health and productivity challenges when affected by chronic kidney disease (CKD) due to hypertension.
PURPOSE: To create machine learning (ML) models based on inflammatory markers and coagulation parameters for predicting intraoperative hemodynamic Instability (HI) in sustained hypertensive patients with pheochromocytomas and paragangliomas (PPGLs).
The escalating global burden of chronic kidney disease (CKD), particularly end-stage renal disease (ESRD), has intensified reliance on hemodialysis (HD), imposing substantial financial and operational burdens on healthcare systems and patients. Intra...
Uncontrolled hypertension (HTN) increases the risk of adverse health events. This study aimed to identify key predictors of uncontrolled HTN in 1,308 Mexican adults with a prior diagnosis of HTN who were undergoing pharmacological treatment. We utili...
The renin-angiotensin system (RAS) is central to cardiovascular diseases such as hypertension and cardiomyopathy, yet the functions of many RAS genes remain unclear. This study developed a multi-label deep learning model to systematically annotate RA...
BMC medical informatics and decision making
Jul 31, 2025
BACKGROUND: Stroke is one of the leading causes of death and disability worldwide, with a significantly elevated incidence among individuals with hypertension. Conventional risk assessment methods primarily rely on a limited set of clinical parameter...
Ibrutinib and acalabrutinib are first- and next-generation Bruton Tyrosine Kinase inhibitors (BTKi), respectively, approved for chronic lymphocytic leukemia (CLL). Ibrutinib has been associated with cardiovascular events, including atrial fibrillatio...
Journal of health, population, and nutrition
Jul 30, 2025
INTRODUCTION: Observational studies have indicated that individuals with hypertension (HTN) and diabetes mellitus (DM) tend to exhibit elevated plasma atherogenic index of plasma (AIP), defined as log (triglyceride [TG]/high-density lipoprotein chole...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.